What is the recommended dosing of propranolol (beta blocker) for anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol Dosing for Anxiety in Adults

For anxiety in adults, propranolol should be dosed at 10-40 mg taken 30-60 minutes before anxiety-provoking situations for performance anxiety, or 20-40 mg two to three times daily (total 80-120 mg/day) for generalized anxiety with prominent somatic symptoms, with doses up to 320 mg/day used in some cases.

Patient Selection

Propranolol is most effective for anxiety characterized by prominent somatic/physical symptoms rather than purely psychological symptoms 1, 2. Target patients include those with:

  • Tremor, palpitations, tachycardia, and sweating 1
  • Performance anxiety (public speaking, social phobias) 3
  • Moderate intensity anxiety, particularly in primary care settings 3
  • Recent onset anxiety not meeting criteria for chronic anxiety disorders 3

Propranolol is less effective for purely psychic anxiety (worry, rumination) without somatic manifestations 2.

Mandatory Pre-Treatment Assessment

Before initiating propranolol, perform 1:

  • Heart rate and blood pressure measurement
  • Cardiovascular examination with auscultation
  • Screen for history of bronchospasm, diabetes, and cardiac conduction abnormalities

Absolute Contraindications

Do not use propranolol in patients with 1:

  • Second or third-degree heart block
  • Decompensated heart failure or significant left ventricular dysfunction
  • Asthma or reactive airway disease
  • Cardiogenic shock or severe hypotension
  • Recent or ongoing hypoglycemic episodes
  • Sinus node dysfunction without a pacemaker

Dosing Regimens

For Performance Anxiety (Situational)

  • 10-40 mg as a single dose taken 30-60 minutes before the anxiety-provoking event 3
  • This is the most common use in clinical practice for public speaking, presentations, or specific social situations 3

For Generalized Anxiety with Somatic Symptoms

Starting dose: 20-40 mg once to three times daily 3, 4

Typical therapeutic range: 80-320 mg daily in divided doses 4, 5

Dose titration: Adjust to achieve clinical response and significant beta-blockade (virtual abolition of orthostatic and hyperventilatory tachycardia) 4

Maximum doses: Some patients required up to 1200 mg daily for intense symptoms in long-term studies, though 80-320 mg sufficed for most 4

Administration Guidelines

  • Administer with food to reduce hypoglycemia risk 1
  • Hold doses during diminished oral intake or vomiting 1
  • Monitor for hypotension and bradycardia, especially during dose escalation 1

Duration of Treatment

  • Short-term use (days to weeks) is typical for performance anxiety 3
  • Clinical efficacy beyond 4 weeks for chronic anxiety remains incompletely demonstrated 3
  • Long-term use (months to years) has been reported in clinical practice with good tolerance 4

Common Pitfalls and Safety Considerations

Abrupt discontinuation: Never stop propranolol suddenly after chronic use, as this can precipitate rebound hypertension, tachycardia, or angina—taper gradually 1

Common adverse effects include 1:

  • Fatigue and dizziness (often difficult to distinguish from anxiety symptoms) 6
  • Bradycardia and hypotension
  • Cold extremities
  • Potential worsening of heart failure

Depression concerns: While depression lifted in many anxious patients on propranolol, it may persist or worsen in predisposed individuals 3, 4

Cognitive effects: Potential impairment of cognitive function remains controversial 3

Masking hypoglycemia: Propranolol may mask symptoms of hypoglycemia in diabetic patients 1

Comparative Effectiveness

Research suggests that diazepam is generally more effective than propranolol for overall anxiety relief, but propranolol outperforms placebo specifically in patients with somatic anxiety 2. Propranolol should be considered as an alternative to benzodiazepines, particularly to avoid psychomotor impairment and dependence 3, 5.

References

Guideline

Medication Transition from Flupentixol/Melitracen to Propranolol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Propranolol in the treatment of anxiety.

Postgraduate medical journal, 1976

Research

The treatment of anxiety with beta-blocking drugs.

Postgraduate medical journal, 1988

Research

Propranolol in chronic anxiety disorders. A controlled study.

Archives of general psychiatry, 1980

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.